Sarah Meshberg-Cohen, PhD
Biography
Research & Publications
News
Appointments
Biography
Sarah Meshberg-Cohen, Ph.D., is a clinical psychologist with a background in behavioral medicine, and specializes in the treatment of substance use disorders, chronic depression, anxiety, posttraumatic stress disorder (PTSD), and dual diagnosis. Dr. Meshberg-Cohen serves as the Director of the VACHS Outpatient Addiction Recovery Service and Program Manager of VACHS Addiction Firm. Her clinical work utilizes evidence-based treatments, including cognitive behavioral therapy, motivational enhancement, cognitive processing therapy, written exposure therapy, and cognitive behavioral analysis system of psychotherapy (CBASP). Her research focuses on improving evidence-based treatments for substance use disorders and comorbid psychiatric conditions, often involving trauma. She is the Principal Investigator on a grant-funded randomized clinical trial investigating the feasibility and efficacy of written exposure therapy (WET) for veterans seeking SUD treatment who present with comorbid PTSD. Dr. Meshberg-Cohen also serves as co-Investigator on a clinical trial examining the impact of cognitive processing therapy with buprenorphine maintenance for veterans with comorbid opioid use disorder and PTSD.
Education & Training
- Post-Doctoral AssociateYale University School of Medicine (2012)
- PhDVirginia Commonwealth University (2010)
- Pre-Doctoral FellowYale University School of Medicine (2010)
- MSVirginia Commonwealth University (2006)
- BASkidmore College, Psychology (2002)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Distinguished Psychologist for Contributions to Clinical Care | VA Connecticut Healthcare System | 2023 |